MD Anderson Research Highlights for Sept. 21, 2023
September 22, 2023
September 22, 2023
HOUSTON, Texas, Sept. 22 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following research highlight:
* * *
Featuring microbiome insights, targets to overcome KRAS inhibitor resistance, a novel approach to sensitize glioblastoma to immunotherapy, and a new drug for AML
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevent . . .
* * *
Featuring microbiome insights, targets to overcome KRAS inhibitor resistance, a novel approach to sensitize glioblastoma to immunotherapy, and a new drug for AML
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevent . . .